文献速递主动脉疾病

破裂腹主动脉瘤修复术后短期死亡率在不同中心和医生间的差异

Variability in short-term mortality following repair of ruptured abdominal aortic aneurysms across centers and physicians.
PubMed 文献 · J Vasc Surg · 2024-05-09

基于血管质量倡议数据库2013–2019年数据,分析450例破裂开放修复(rOSR)和752例破裂腔内修复(rEVAR),链接医保索赔获取30天和90天全因死亡率。rOSR后中心和医生间无变异;rEVAR后中心间存在显著变异(30天MOR 1.82,ICC 11%),医生间变异可忽略。年手术量未显著解释这些关联。

要点

  • rOSR后30天和90天死亡率分别为32.9%和38.7%,中心和医生间无变异(MOR≈1,ICC≈0%)。
  • rEVAR后30天和90天死亡率分别为21.3%和25.5%,中心间存在显著变异(30天MOR 1.82,ICC 11%)。
  • rEVAR后医生间变异可忽略(MOR≈1,ICC≈0%),中心和医生年手术量均未显著解释死亡率变异。

核心结论

  • rEVAR术后短期死亡率存在中心间变异,而rOSR术后未见中心间变异;医生间变异在rOSR和rEVAR术后均未观察到。
  • 中心和医生年手术量未显著解释上述关联,需进一步研究识别影响破裂腹主动脉瘤诊疗质量和结局的中心层面因素。

研究设计与样本

  • 回顾性队列分析,数据来自血管质量倡议数据库2013–2019年rOSR和rEVAR手术,链接医保索赔数据获取30天和90天全因死亡率。
  • 纳入450例rOSR(平均年龄74.5±7.6岁,女性23.5%)和752例rEVAR(平均年龄76.4±8.4岁,女性26.1%)。
  • 采用患者水平校正的多层logistic回归模型计算中位比值比(MOR)和组内相关系数(ICC),并按手术量四分位数分层序贯校正。

主要发现

  • rOSR后30天和90天死亡率分别为32.9%和38.7%,中心和医生间无变异(30天和90天MOR≈1,ICC≈0%)。
  • rOSR后中心和医生手术量均与30天死亡率(P=.477和P=.796)及90天死亡率(P=.098和P=.559)无显著关联。
  • rEVAR后30天和90天死亡率分别为21.3%和25.5%,中心间存在显著变异(30天MOR 1.82[95%CI 1.33-2.22],ICC 11%[95%CI 2%-36%];90天MOR 1.76[95%CI 1.37-2.09],ICC 10%[95%CI 3%-30%])。
  • rEVAR后医生间变异可忽略(30天和90天MOR≈1,ICC≈0%),中心和医生手术量均与30天死亡率(P=.076和P=.336)及90天死亡率(P=.066和P=.584)无显著关联。
  • 归因于手术量的中心变异可忽略(ICC差值:30天死亡率1%,90天死亡率0%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Variation in the care management of repairs for ruptured infrarenal abdominal aortic aneurysms between centers and physicians, such as procedural volumes, may explain differences in mortality outcomes. First, we quantified the center and physician variability associated with 30- and 90-day mortality risk after ruptured open surgical repair (rOSR) and ruptured endovascular aneurysm repair (rEVAR). Second, we explored wheter part of this variability was attributable to procedural volume at the center and physician levels. METHODS: Two cohorts including rOSR and rEVAR procedures between 2013 and 2019 were analyzed from the Vascular Quality Initiative database. Thirty- and 90-day all-cause mortality rates were derived from linked Medicare claims data. The median odds ratio (MOR) (median mortality risk from low- to high-risk cluster) and intraclass correlation coefficient (ICC) (variability attributable to each cluster) for 30- and 90-day mortality risks associated with center and physician variability were derived using patient-level adjusted multilevel logistic regression models. Procedural volume was calculated at the center and physician levels and stratified by quartiles. The models were sequentially adjusted for volumes, and the difference in ICCs (without vs with accounting for volume) was calculated to describe the center and physician variability in mortality risk attributable to volumes. RESULTS: We included 450 rOSRs (mean age, 74.5 ± 7.6 years; 23.5% female) and 752 rEVARs (76.4 ± 8.4 years; 26.1% female). After rOSRs, the 30- and 90-day mortality rates were 32.9% and 38.7%, respectively. No variability across centers and physicians was noted (30- and 90-day MORs ≈1 and ICCs ≈0%). Neither center nor physician volume was associated with 30-day (P = .477 and P = .796) or 90-day mortality (P = .098 and P = .559). After rEVAR, the 30- and 90-day mortality rates were 21.3% and 25.5%, respectively. Significant center variability (30-day MOR, 1.82 [95% confidence interval (CI), 1.33-2.22]; ICC, 11% [95% CI, 2%-36%]; and 90-day MOR, 1.76 [95% CI, 1.37-2.09]; ICC, 10% [95% CI, 3%-30%]), but negligeable variability across physicians (30- and 90-day MORs ≈1 and ICCs ≈0%) were noted. Neither center nor physician volume were associated with 30-day (P = .076 and P = .336) or 90-day mortality risk (P = .066 and P = .584). The center variability attributable to procedural volumes was negligeable (difference in ICCs, 1% for 30-day mortality; 0% for 90-day mortality). CONCLUSIONS: Variability in practice from center to center was associated with short-term mortality outcomes in rEVAR, but not for rOSR. Physician variability was not associated with short-term mortality for rOSR or rEVAR. Annualized center and physician volumes did not significantly explain these associations. Further work is needed to identify center-level factors affecting the quality of care and outcomes for ruptured abdominal aortic aneurysms.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Romain G, Wang K, Scierka LE, et al. Variability in short-term mortality following repair of ruptured abdominal aortic aneurysms across centers and physicians. J Vasc Surg. 2024. PMID: 38729585. doi:10.1016/j.jvs.2024.05.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。